Literature DB >> 24194112

Prevention and reversible solubilization of advanced glycation and products (AGE) by organic germanium compounds as derivatives of amino acids.

K Nakamura1, K Nomoto, K Kariya, Y Nakajima, H Nishimoto, S Uga, M Miyata, T Osawa, S Kawakishi, N Kakimoto.   

Abstract

The amino-carbonyl reaction (The Maillard reaction) of bovine lens crystallin, serum albumin or skin collagen with glucose was investigated to find effective means to prevent the formation of Advanced Glycation End Products (AGE) and induce the reversible solubilization of polymerized glycated proteins. The organic germanium compounds (Ge-132, 373, 385), derivatives of amino acids containing germanium as the linker of framework, were combined by the box titration method to determine the dose that would be most effective, compared with Aminoguanidine-HCl (AMG),α-tocopherol (VE), and pirenoxine (Catalin-K, CK). Although AMG suppressed the formation of AGE, effective concentrations were higher than 20 mM. Ge-385, when administered by itself at a low dose, induced the reversible solubilization of AGE made from crystallin, and albumin. The addition of any two reagents such as AMG, VE, CK and Ge-132 or 385 together to proteins lessened the effective range, and the peaks of smaller molecules in the profiles of HPLC and PAGE were quite remarkable. Examination was made of the effects of Ge-132 on the eyes of SAM mice, which show senescence accelerated cataracts at a relatively young age. The prevention of cataract-genesis and induction of reversible transparency of turbid lenses became evident following the administration of Ge-132 to the eyes 4 times a day. The mode of action of organic germanium compounds was demonstrated quite capable of disconnecting the sugar-parts from AGE by decarbonylation, resulting in the formation of glucosone and amino residues, and further leading subsequently to fewer AGE.

Entities:  

Year:  1991        PMID: 24194112     DOI: 10.1007/BF00806925

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  5 in total

Review 1.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Authors:  M Brownlee; A Cerami; H Vlassara
Journal:  N Engl J Med       Date:  1988-05-19       Impact factor: 91.245

2.  Cataract in senescence accelerated mouse (SAM). 2. Development of a new strain of mouse with late-appearing cataract.

Authors:  M Hosokawa; Y Ashida; T Tsuboyama; W H Chen; T Takeda
Journal:  Exp Eye Res       Date:  1988-10       Impact factor: 3.467

3.  Accelerated age-related browning of human collagen in diabetes mellitus.

Authors:  V M Monnier; R R Kohn; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.

Authors:  M Brownlee; H Vlassara; A Kooney; P Ulrich; A Cerami
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

5.  A new murine model of accelerated senescence.

Authors:  T Takeda; M Hosokawa; S Takeshita; M Irino; K Higuchi; T Matsushita; Y Tomita; K Yasuhira; H Hamamoto; K Shimizu; M Ishii; T Yamamuro
Journal:  Mech Ageing Dev       Date:  1981-10       Impact factor: 5.432

  5 in total
  1 in total

Review 1.  The Possible Positive Mechanisms of Pirenoxine in Cataract Formation.

Authors:  Phit Upaphong; Chanisa Thonusin; Janejit Choovuthayakorn; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.